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Autosomal-dominant polycystic kidney disease, the
most frequent monogenic cause of kidney failure, is
induced by mutations in the PKD1 or PKD2 genes,
encoding polycystins TRPP1 and TRPP2, respec-
tively. Polycystins are proposed to form a flow-sensi-
tive ion channel complex in the primary cilium of
both epithelial and endothelial cells. However, how
polycystins contribute to cellular mechanosensitivity
remains obscure. Here, we show that TRPP2 inhibits
stretch-activated ion channels (SACs). This specific
effect is reversed by coexpression with TRPP1, indi-
cating that the TRPP1/TRPP2 ratio regulates pres-
sure sensing. Moreover, deletion of TRPP1 in smooth
muscle cells reduces SAC activity and the arterial
myogenic tone. Inversely, depletion of TRPP2 in
TRPP1-deficient arteries rescues both SAC opening
and the myogenic response. Finally, we show that
TRPP2 interacts with filamin A and demonstrate
that this actin crosslinking protein is critical for SAC
regulation. This work uncovers a role for polycystins
in regulating pressure sensing.
INTRODUCTION
Autosomal-dominant polycystic kidney disease (ADPKD) is a
multisystem disorder characterized by renal and extrarenal
cysts, as well as cardiovascular abnormalities (Arnaout, 2001;
Delmas, 2004; Harris and Torres, 2009). Mutations in either
PKD1 or PKD2 gene, encoding polycystin-1 (TRPP1) or -2
(TRPP2), respectively (for recent nomenclature see Nilius et al.,
2007), account for this common hereditary disease (Harris and
Torres, 2009). TRPP1 is a large integral membrane glycoprotein
with 11 transmembrane domains and an extensive amino-
terminal extracellular domain involved in cell-cell, cell-matrixinteraction and signaling pathways (for review see Wilson,
2004). TRPP1 interacts with TRPP2, a six transmembrane
domain protein of the TRP ion channel family (for review see Gia-
marchi et al., 2006). Polycystins also interact with multiple part-
ners, including the TRP channel subunits TRPC1 and TRPV4
(Kottgen et al., 2008; Tsiokas et al., 1999), as well as several
elements of the cytoskeleton (for reviews see Chen et al.,
2008; Delmas, 2004; Harris and Torres, 2009; Wilson, 2004).
By associating through the coiled-coil motifs in their cytosolic
carboxy-terminal domains, TRPP1 and TRPP2 have been pro-
posed to form a ‘‘receptor-ion channel complex’’ (Hanaoka
et al., 2000). TRPP1 and TRPP2 colocalize at the membrane of
the primary cilia of renal epithelial cells and endothelial cells where
they are proposed to transduce luminal shear stress (i.e., fluid flow
parallel to the cell surface) into a calcium signal (Nauli et al., 2003,
2008). With its large extracellular amino-terminal domain, TRPP1
has been suggested to be a mechanical sensor regulating the
opening of the associated calcium-permeable channel TRPP2
(Nauli et al., 2003). Loss of this mechanosensory function (i.e.,
flow sensing) is thought to result in altered cellular signaling
subsequently leading to cyst formation (Nauli and Zhou, 2004).
In endothelial primary cilia, as reported in kidney epithelial
cells (Nauli et al., 2003), TRPP1 and TRPP2 are also involved in
fluid shear sensing and regulate calcium signaling and nitric
oxide release, thus contributing to vasodilation in response to
an increase in blood flow (Aboualaiwi et al., 2009; Nauli et al.,
2008). However, polycystins are also abundantly expressed in
arterial myocytes (Boulter et al., 2001; Qian et al., 2003), which
respond to intraluminal pressure that causes wall stretch,
instead of flow. An increase in intraluminal pressure causes
a gradual depolarization of the vascular smooth muscle cells
(VSMCs) that is linked to the opening of nonselective stretch-
activated cation channels (SACs), followed by the opening of
voltage-gated calcium channels, resulting in an increase in intra-
cellular Ca2+ and myocyte constriction (the myogenic or Bayliss
response) (Brayden et al., 2008; Hill et al., 2006; Voets and Nilius,
2009). The possible involvement of polycystins in pressure
sensing has not yet been investigated.Cell 139, 587–596, October 30, 2009 ª2009 Elsevier Inc. 587
Figure 1. SAC Inhibition by TRPP2
(A) Single-channel currents recorded in the cell-attached patch configuration and induced by increasing negative pipette pressure (0, 10, and 30 mm Hg) in
a mock-transfected COS-7 cell at a holding potential of 80 mV. SAC activity was significantly inhibited (67%, n = 18) by the cup-former cationic amphipath
chlorpromazine (50 mM; not shown).
(B) Mean (± standard error of the mean [SEM]) i-V relationship of single SACs from mock-transfected COS-7 cells stimulated with a negative (30 mm Hg) pres-
sure pulse in the inside out configuration (n = 6).
(C) Mean SAC currents in COS-7 cells transfected with mock, hTRPP1, hTRPP2, and hTRPP1 + hTRPP2 plasmids at a holding potential of 80 mV in the cell-
attached patch configuration.
(D) Mean (±SEM) NPo as a function of pressure in cells transfected with the control, hTRPP1, and hTRPP2. Data are fitted with Boltzmann functions (P0.5 =21.7 ±
2.4; 16.1 ± 2.0; and 24.6 ± 5.6 mm Hg; k = 6.1 ± 0.8; 4.3 ± 0.6; and 8.2 ± 1.8; for control, hTRPP1 and hTRPP2 transfected cells, respectively). (Inset) Dose-
dependent SAC inhibition by TRPP2 (n = 31, 10, 20, and 30).
(E) Relative mean (±SEM) NPo at60 mm Hg for control, hTRPP1, hTRPP2 (or hTRPP2-742X), and hTRPP1 and hTRPP2 (or hTRPP2-742X) cotransfected. n = 40,
40, 30, 40, 20, and 22, for control, hTRPP1, hTRPP2, hTRPP1+hTRPP2, hTRPP2-742X, and hTRPP1+hTRPP2-742X, respectively.Here, we demonstrate that the TRPP1/TRPP2 ratio regulates
SAC activity via the filamin A (FLNa)/F-actin cytoskeletal network
and modulates the arterial myogenic response to intraluminal
pressure.
RESULTS
TRPP2 Expression Reduces SAC Activity
To determine the effect of TRPP1 and TRPP2 on SAC activity, we
expressed the proteins either individually or together in COS
cells, an expression system previously used to study mechano-
sensitive ion channels (Gottlieb et al., 2007; Honore´ et al., 2006).
In cell-attached recordings of mock-transfected cells, brief
negative pressure pulses applied through the recording elec-
trode evoked a gradual and reversible opening of endogenous588 Cell 139, 587–596, October 30, 2009 ª2009 Elsevier Inc.cation nonselective SACs (Figure 1A), with a single-channel
conductance of 29.2 ± 0.3 pS and a reversal potential (Erev) of
0.1 ± 0.3 mV (n = 13; Figure 1B). Surprisingly, while overexpres-
sion of TRPP1 alone had no significant effect (Figure 1C), over-
expression of TRPP2 produced a dramatic and dose-dependent
inhibition of SAC activity (Figures 1C and 1D, inset, and
Figure 1E). Neither single-channel conductance, ionic selectivity
(see Figure S1 available online), or open probability in patches
with a single channel were changed by TRPP2 overexpression.
The percentage of active patches was reduced from 94% ±
1% (n = 264) in mock-transfected cells to 70% ± 5% in cells
expressing TRPP2 (p < 0.001, n = 90; data not shown). Interest-
ingly, SAC inhibition was also observed with a disease-causing
TRPP2 mutant in which a nonsense mutation generates a trun-
cated form of TRPP2 (hTRPP2-742X or the mouse equivalent
Figure 2. Pkd1 Inactivation Reduces SAC
Activity in Vascular Smooth Muscle Cells
(A) Single-channel currents (cell-attached patch
configuration) induced by negative pipette pres-
sures in a Pkd1+/+ VSMC at a holding potential
of 80 mV.
(B) Mean currents in isolated VSMCs fromPkd1+/+,
Pkd1SMdel/+, or Pkd1SMdel/del mice. Sample
numbers for (B), (C), and (E) are: n = 70, 46, and
64 for Pkd1+/+, Pkd1SMdel/+, and Pkd1SMdel/del
cells, respectively.
(C) Mean (±SEM) pressure-dependent SAC
activity (NPo). Data are fitted with Boltzmann func-
tions (P0.5 =41.8 ± 2.9;43.9 ± 4.9; and42.7 ±
3.5 mm Hg; k = 13.8 ± 2.3; 13.3 ± 4.0; 8.8 ± 2.9; for
Pkd1+/+, Pkd1SMdel/+, and Pkd1SMdel/del cells,
respectively).
(D) Mean (±SEM) i-V relationships of single SACs
from Pkd1+/+ (white circles; n = 11), Pkd1SMdel/+
(gray circles; n = 18), and Pkd1SMdel/del (black
circles; n = 8) VSMCs at 50 mm Hg.
(E) Mean percentage (±SEM) of active patches
at 100 mm Hg for Pkd1+/+ (white bars),
Pkd1SMdel/+ (gray bars), and Pkd1SMdel/del (black
bars) cells.
(F) Mean (±SEM) nifedipine (2 mM)-sensitive
barium currents recorded in the whole-cell con-
figuration in Pkd1+/+ (n = 17) and Pkd1SMdel/del
(n = 15) VSMCs. (Inset) Nifedipine-sensitive barium
currents in a Pkd1+/+ VSMC stimulated from
60 mV to 50, 10, and 10 mV.mTRPP2-740X) lacking the ER retention signal (Figures 1E, S2A,
and S6) (Mochizuki et al., 1996). This inhibitory effect of TRPP2
on SACs was also present in cell lines originating from different
tissues including renal epithelium (LLC-PK1), dorsal root
ganglion neurons (F11), and vascular smooth muscle (MOVAS,
A7R5, and mouse aortic explants), thus probably representing
a fundamental cellular property (Figure S2A). The effect of
TRPP2 expression was selective for SACs, as the activity of
other channel types, including ASIC and Kv, were not modified
by TRPP2 overexpression (Figures S2B and S2C). Moreover,
other TRP channels shown to directly interact with TRPP2 and/
or claimed to be implicated in mechanotransduction (Christen-
sen and Corey, 2007; Gottlieb et al., 2007; Kottgen et al., 2008;
Maroto et al., 2005; Pedersen and Nilius, 2007; Spassova
et al., 2006; Tsiokas et al., 1999), including TRPC1, TRPV4 and
TRPC6, failed to affect SAC activity (Figure S2D).
TRPP1 Reverses SAC Inhibition by TRPP2
Interestingly, coexpression of TRPP1 with TRPP2 reversed the
inhibitory effect of TRPP2 on SACs (Figures 1C and 1E). To
examine whether the reversal by TRPP1 requires an interaction
with TRPP2, we expressed TRPP1 with TRPP2-742X, which
lacks the coiled-coil TRPP1 binding domain. TRPP1 could not
rescue SAC activity in TRPP2-742X-transfected COS cells (Fig-
ure 1E), demonstrating that the reversal of SAC inhibition is
dependent on an interaction between TRPP1 and TRPP2. More-
over, this reversal was specific to TRPP1, as coexpression with
either TRPC1 or TRPV4, also known to interact with TRPP2 (Kott-gen et al., 2008; Tsiokas et al., 1999), failed to reverse SAC inhi-
bition by TRPP2 (Figure S2D). These observations indicate that
the dosage of TRPP2 relative to TRPP1 modulates the activity
of SACs in expression systems. Here, we detected no significant
exogenous channel current expression at the plasma membrane
after transient transfection of TRPP1 and/or TRPP2 (wild-type
[WT] or 742X) in both MOVAS (data not shown) and COS cells
using either single channel or whole cell patch clamp recording
configurations (Figure S7).
Pkd1 Inactivation Reduces SAC Activity in Arterial
Myocytes
If the TRPP1/TRPP2 dosage modulates SAC activity in a native
system known to express both polycystins, we would expect
that lowering the expression of TRPP1 may cause a TRPP2-
mediated inhibition of SAC activity. We inactivated the Pkd1
gene selectively in mouse smooth muscle cells using the Cre/
lox strategy (with no alteration in the level of expression of
Pkd2 or other relevant TRP subunits; see Experimental Proce-
dures) (Holtwick et al., 2002) and examined SAC activity in
VSMCs acutely dissociated from resistance mesenteric arteries
of Pkd1+/+, Pkd1SMdel/+, or Pkd1SMdel/del mice. Measurements
of arterial pressure revealed no significant difference between
the Pkd1 genotypes (Figure S8). In cell-attached patches, brief
negative pressure pulses applied through the recording elec-
trode evoked a gradual and reversible opening of SACs (Fig-
ure 2A) with biophysical properties similar to those found in
COS cells (single-channel conductance: 28.5 ± 0.4 pS; n = 11).Cell 139, 587–596, October 30, 2009 ª2009 Elsevier Inc. 589
The variability in kinetics (Figures 1C and 2B) can be explained by
different viscoelastic properties between VSMCs and COS cells
(Sachs and Morris, 1998). Ionic substitutions (Erev: 3.5 ±
2.1 mV, n = 11, with NaCl; 5.2 ± 3.2 mV, n = 12, with sodium
gluconate; 30.5 ± 3.8 mV, n = 4, with choline chloride; Fig-
ure 2D and data not shown), as well as pharmacological exper-
iments, indicated that these channels were cationic, nonselec-
tive, and inhibited by classical blockers of SACs (78.0 ±
14.0%, n = 13, with 30 mM Gd3+ and 89.0 ± 9.0%, n = 7, with
5 mM GsTMx4). Moreover, pressure-induced inward SAC
currents at negative membrane potentials could be recorded
when Ca2+ (or Ba2+) was the only possible charge carrier, thus
indicating Ca2+ permeability of the channel (Figure S9). Remark-
ably, the activity of SACs was significantly lower in VSMCs from
Pkd1SMdel/+ and Pkd1SMdel/del compared to Pkd1+/+ mice (Fig-
ures 2B and 2C). The GsTMx4-sensitive SACs component was
significantly smaller in arterial myocytes from Pkd1SMdel/del
mice, as compared to those isolated from Pkd1+/+ mice (Fig-
ure S10). Neither the single-channel conductance (Figure 2D)
nor the open channel probability (Po) changed in patches with
a single channel, indicating that the number of active SACs is
decreased in VSMCs from Pkd1SMdel/+ and Pkd1SMdel/del
mice. Indeed, the percentage of active patches (i.e., with SAC
opening) was significantly lower in VSMCs of Pkd1SMdel/+
and Pkd1SMdel/del mice (Figure 2E). The density of the L-type
voltage-dependent calcium current, which plays a key role in
arterial excitation-contraction coupling, was not different
between mesenteric VSMCs isolated from Pkd1+/+ and
Pkd1SMdel/del mice (5.61 ± 0.81 pA/pF in Pkd1+/+ compared to
6.05 ± 1.17 pA/pF in Pkd1SMdel/del; at +10 mV; Figure 2F). These
data show that in VSMCs reducing TRPP1 expression causes
a specific decrease in SAC activity.
Pkd1 Inactivation Impairs the Arterial Myogenic
Response
Stretch-activated channels are known to be involved in the
myogenic tone, a key function of resistance arteries in response
to an increase in intraluminal pressure (Brayden et al., 2008; Hill
et al., 2006; Lee et al., 2007; Mederos y Schnitzler et al., 2008).
Indeed, specific pharmacological inhibition of SACs with the
spider toxin GsMTx4 (Suchyna et al., 2000) significantly reduced
the myogenic tone of resistance mesenteric arteries (Fig-
ure S11). Because the activity of SACs was significantly reduced
in the absence of TRPP1, we examined whether the myogenic
contractility of resistance arteries may also be affected. Mesen-
teric arteries isolated from Pkd1+/+ mice produced a robust
myogenic contraction when intraluminal pressure was increased
(Figures 3A and 3B). However, arteries isolated fromPkd1SMdel/+
and Pkd1SMdel/del mice showed a profound decrease in
myogenic tone (Figures 3A and 3B). Furthermore, the threshold
pressure for myogenic contraction was significantly shifted to
higher pressure in arteries with decreased Pkd1 expression
(Figure 3B). This indicates that these arteries have to be dis-
tended further before triggering mechanosensory feedback
(Figures 3A and 3B). Additionally, we observed no change in
vascular reactivity to KCl or phenylephrine in mesenteric arteries
from 12- to 16-week-old Pkd1SMdel/del mice (Figure 3C), which
confirms findings from a related study using 20-week-old Pkd1590 Cell 139, 587–596, October 30, 2009 ª2009 Elsevier Inc.(global) heterozygote mice (Morel et al., 2009). These results
support the assumption that L-type calcium channel activity
was unchanged and that intracellular calcium stores, as well as
the contractile apparatus, were not significantly altered by
Pkd1 deletion. Finally, the wall/lumen ratio did not vary between
genotypes (Figure S3A). Moreover, the stress-strain curves of
mesenteric arteries were identical (Figure S3B), indicating that
the contribution of elastin and collagen to arterial wall elasticity
was unaltered by Pkd1 inactivation. Thus, the expression of
Figure 3. Pkd1 Inactivation Impairs the Mesenteric Artery Myogenic
Response
(A) Changes in lumen diameter in Pkd1+/+ (top panel) and Pkd1SMdel/del (lower
panel) arteries as a function of pressure. Black traces represent the active
curve in the presence of 2.5 mM CaCl2 and red traces represent the passive
curve (distensibility) in the absence of CaCl2 and the presence of sodium nitro-
prusside, papaverine, and EGTA.
(B) Mean (±SEM) myogenic tone (percentage of passive diameter) in Pkd1+/+
(white symbols), Pkd1SMdel/+ (gray symbols), and Pkd1SMdel/del (black
symbols) arteries. Data are fitted with Boltzmann functions (P0.5 = 78.5 ± 3.7;
94.2 ± 8.0; and 101.4 ± 8.5 mm Hg; k = 14.2 ± 2.5; 11.5 ± 2.7; 7.0 ± 1.7; for
Pkd1+/+, Pkd1SMdel/+, and Pkd1SMdel/del arteries, respectively).
(C) Mean (±SEM) KCl- and phenylephrine-induced contractions in the three
genotypes at 75 mm Hg.
TRPP1 in VSMCs appears essential for pressure-dependent
mesenteric artery SAC activity and myogenic tone, but does
not affect other arterial properties.
Depletion of TRPP2 in TRPP1-Deficient VSMCsRestores
Both SAC Activity and Myogenic Tone
We hypothesized that when TRPP2 is released from its inter-
action with TRPP1, either by lowering TRPP1 expression
(Pkd1SMdel/+ or Pkd1SMdel/del) or by overexpressing TRPP2, it
impairs SAC activity and lowers myogenic tone. Therefore,
reducing the expression of TRPP2 in arteries lacking Pkd1
should restore SAC opening and consequently the myogenic
tone. Indeed, knocking down Pkd2 by about 80% with an siRNA
(Figure S4) increased SAC activity in Pkd1SMdel/del VSMCs and
the percentage of active patches (Figures 4A–4C). Additionally,
Pkd2 knockdown restored myogenic tone in Pkd1SMdel/del
mesenteric arteries (Figures 4D and 4E). These results suggest
that free TRPP2 (unbound to TRPP1) is responsible, at least in
large part, for the decrease in SAC function and myogenic tone
in Pkd1SMdel/+ and Pkd1SMdel/del arteries.
Role of the Actin Cytoskeleton in SAC
Inhibition by TRPP2
The cortical F-actin cytoskeleton exerts a tonic inhibitory con-
trol over SAC activity, presumably by reducing the amount
of stretch-induced increase in bilayer tension sensed by the
channel protein (Lauritzen et al., 2005; Morris, 2001). Because
TRPP2 is known to interact with various cytoskeletal elements
(for reviews see Chen et al., 2008; Delmas, 2004; Harris and
Torres, 2009; Wilson, 2004), we examined whether SAC inhibi-
tion by the F-actin cytoskeleton may be enhanced in the pres-
ence of TRPP2. Using the actin monomer-sequestering agent
latrunculin A, we demonstrate that disruption of the F-actin cyto-
skeleton increased SAC activity in COS cells (Figures 5A and 5B),
thus confirming the tonic inhibitory influence of the actin cyto-
skeleton. A similar effect on SAC activity was observed when
we used the barbed-end capping agent cytochalasin D at con-
centrations known to induce F-actin depolymerization through
capping-induced growth arrest and actin dimer formation
(Figure 5B). Remarkably, these treatments fully reversed SAC
inhibition by TRPP2 in COS cells and restored channel activity
(Figures 5A and 5B). Latrunculin A similarly increased SAC
activity in VSMCs from Pkd1SM+/+ and Pkd1SMdel/del arteries
and suppressed the difference between both genotypes (Fig-
ure 5C). However, microtubule-disrupting agents, including
colchicine or nocodazole, did not modify SAC inhibition by
TRPP2 (Figure 5B). Conversely, actin stabilization by jasplakino-
lide inhibited SAC activity and mimicked the effect of TRPP2 in
COS cells (Figure 5B). These data demonstrate that the F-actin
cytoskeleton is involved in SAC inhibition by TRPP2.
Filamin A Interacts with TRPP2 and Is Required for SAC
Inhibition
In a search for proteins that bind to TRPP2, we performed a pro-
teomic screen in the mouse VSMC line MOVAS. Besides known
TRPP2 partners, including TRPP1 and the InsP3 receptor, we
identified the actin crosslinking protein FLNa (Glogauer et al.,
1998; Kainulainen et al., 2002; Stossel et al., 2001) (Table S1).Immunoprecipitation in cotransfected cells confirmed this inter-
action (Figures 6A and S12). To determine whether the effect of
TRPP2 on SAC activity is dependent on FLNa, we expressed
TRPP2 in a human melanoma cell line (M2 or FLNa KO) that
does not express FLNa and in M2 cells stably transfected with
FLNa (A7 or FLNa WT) (Cunningham et al., 1992) (Figure S5).
The single-channel conductance of SACs was similar in both
cell lines (29.1 ± 0.8 pS for FLNa KO cells, n = 37, compared to
29.2 ± 0.8 pS for FLNa WT cells, n = 27; p = 0.888), but the net
Figure 4. Knocking down TRPP2 Rescues SAC Activity and
Myogenic Tone in the Pkd1 Knockout Mesenteric Arteries
(A) Mean SAC currents in VSMCs treated with siRNA-NT (n = 83 for Pkd1+/+
and 86 forPkd1SMdel/del cells) or siRNA-TRPP2-A (n = 47) at a holding potential
of 80 mV.
(B) Mean (±SEM) SAC activity (NPo at 60 mm Hg) of VSMC from Pkd1+/+
(white bars) and Pkd1SMdel/del (black bars) arteries treated with siRNA-NT
(n = 83 for Pkd1+/+ and 93 for Pkd1SMdel/del cells) or siRNA-TRPP2-A (n = 44
for Pkd1+/+ and 49 for Pkd1SMdel/del cells). *p < 0.05, represents significant
difference fromPkd1+/+ siRNA-NT. Similar results were obtained with a second
siRNA against TRPP2 (siRNA-TRPP2-B; not shown).
(C) Mean (±SEM) percentage of active patches in Pkd1+/+ and Pkd1SMdel/del
cells transfected with either NT or TRPP2-A siRNAs. Same n values as in
(B). Asterisk represents significant difference from Pkd1+/+ siRNA-NT.
(D) Mean (±SEM) myogenic tone (MT) in Pkd1SMdel/del arteries treated with the
siRNA-NT (n = 9) or the siRNA-TRPP2-A (n = 7) as a function of intraluminal
pressure.
(E) Mean (±SEM) myogenic tone (MT) at 75 mm Hg inPkd1+/+andPkd1SMdel/del
arteries treated with siRNA-NT (n = 5 for Pkd1+/+ and 10 for Pkd1SMdel/del) or
siRNA-TRPP2-A (n = 4 for Pkd1+/+ and 9 for Pkd1SMdel/del). **p < 0.01 and
***p < 0.001 represent significant difference from Pkd1SMdel/del siRNA-TRPP2.Cell 139, 587–596, October 30, 2009 ª2009 Elsevier Inc. 591
Figure 5. Disruption of the Actin Cytoskel-
eton Reverses SAC Inhibition by TRPP2
(A) Mean SAC currents (cell attached patch config-
uration) at a holding potential of 80 mV in COS-7
cells transfected with empty expression vector
(mock) or mTRPP2-740X. Cells were incubated
with the vehicle 0.1% DMSO (CTRL) (top panels;
n = 89 and 80 for control and mTRPP2-740X,
respectively) or with 3 mM latrunculin A (bottom
panels; n = 38 and 37 for control and mTRPP2-
740X, respectively) (LTRC) for 1 hr prior record-
ings.
(B) Mean (±SEM) SAC currents in COS-7 cells
expressing empty expression vector (mock shown
in white) or mTRPP2-740X (shown in black). Cells
were incubated with 0.1% DMSO (n = 89 and 80
for mock and mTRPP2-740X, respectively), 3 mM
latrunculin A (LTRC) for 1 hr (n = 38 and 37 for
mock and mTRPP2-740X, respectively), 1 mM
cytochalasin D (cyto D) for 1 hr (n = 10 for both
mock and mTRPP2-740X), 3 mM jasplakinolide
(JASP) for 1 hr (n = 10 for both mock and
mTRPP2-740X), 500 mM colchicine (COL) for 2 hr
(n = 10 for both mock and mTRPP2-740X), or
10 mM nocodazole (NOC) for 1.5 hr (n = 10 for
both mock and mTRPP2-740X). All values are
given as relative to the maximum control current
in the mock transfected cells (80 mm Hg) in the
cell-attached configuration at a holding potential
of 80 mV. The difference between mock and
mTRPP2-740X is only significant (p < 0.05) in the
CTRL, COL, and NOC-treated conditions.
(C) Mean (±SEM) pressure-dependent SAC
activity (NPo) of Pkd1+/+ (left panel) and
Pkd1SMdel/del (right panel) cells recorded in the
cell attached configuration at a holding potential
of 80 mV. Cells were incubated with 0.1%
DMSO (open and closed circles; n = 83 and 45 for Pkd1+/+ and Pkd1SMdel/del, respectively) or with 3 mM latrunculin A (open and closed triangles; n = 68 and
47 for Pkd1+/+ and Pkd1SMdel/del, respectively) for 24 hr before recordings. Data are fitted with Boltzmann functions (P0.5 = 32.1 ± 0.6; 31.0 ± 1.9; 36.7 ±
2.2; and31.0 ± 1.2 mm Hg; k = 5.4 ± 0.5; 4.7 ± 1.8; 5.5 ± 1.9; and 7.2 ± 1.0; for Pkd1+/+ DMSO treated, Pkd1+/+ latrunculin treated, Pkd1SMdel/del DMSO treated,
and Pkd1SMdel/del latrunculin treated, respectively). Dotted curve in the right panel shows the Boltzmann function for DMSO-treated Pkd1+/+ cells. The difference
was significant (p < 0.01) between Pkd1+/+ and Pkd1SMdel/del when DMSO treated, but not after latrunculin A treatment.channel activity was significantly higher in FLNa KO cells
(Figures 6B–6D). Importantly, while the inhibition of SAC activity
by TRPP2 was prominent in FLNa WT cells, it was absent in FLNa
KO cells (Figure 6D). This indicates that FLNa is critically required
for the inhibitory effect of TRPP2 on SACs.
DISCUSSION
Although polycystins have been associated with the mechano-
sensory function of flow sensing in both epithelial and endothelial
cells (Nauli et al., 2003, 2008), how they contribute to cellular
mechanosensitivity still remains unknown. In this study, we
demonstrate that SAC activity is strongly reduced in VSMC
membranes and arterial myogenic tone is impaired when there
is an overabundance of free TRPP2, either by decreasing
TRPP1 or increasing TRPP2. The inhibitory effect is specific to
TRPP2 based on the fact that expression of other TRP channel
subunits, including TRPC1 and TRPC6, has no effect on SAC
activity. Moreover, the activity of Kv and ASIC was unaffected
by TRPP2 overexpression and there was no change in L-type592 Cell 139, 587–596, October 30, 2009 ª2009 Elsevier Inc.Ca2+ channel activity following inactivation of Pkd1, indicating
that TRPP2 specifically regulates the activity of SACs.
Our results differ from the proposed role of the TRPP1/TRPP2
complex as a flow sensor in the primary cilium of renal epithelial
and endothelial cells where inactivation of either TRPP1 or
TRPP2 impairs flow sensing (Nauli et al., 2003, 2008). In VSMCs,
it is the TRPP1/TRPP2 ratio that regulates the activity of native
nonselective cation SACs. In the case of pressure sensing by
arterial myocytes, TRPP2 inhibits mechanosensitivity and
TRPP1 reverses this inhibition, while in the case of flow sensing
by the primary cilium, both TRPP1 and TRPP2 promote mecha-
nosensitivity (Nauli et al., 2003, 2008).
We demonstrated that although TRPP1 and TRPP2 are known
to function as a complex (Hanaoka et al., 2000), TRPP2 can inde-
pendently influence SAC activity, and that TRPP1 reverses this
effect. Other independent functions for TRPP2 have been previ-
ously reported. For instance, in nodal cells, where TRPP1 is
absent, TRPP2 has been implicated in the specification of the
left-right axis (Pennekamp et al., 2002). Antagonism between
TRPP1 and TRPP2 has also been shown in rat sympathetic
neurons where the constitutive activation of Gi/o proteins by
TRPP1 can be reversed by TRPP2 (Delmas et al., 2002). There-
fore, independent function and antagonism between TRPP1 and
TRPP2 are not unique to SAC regulation.
The inhibition of SAC mechanosensitivity by TRPP2 may be
the result of several direct or indirect actions. One possible
mechanism is that free TRPP2 interacts directly with endoge-
nous SACs, thus acting as a dominant-negative subunit. Indeed,
several TRP subunits, some of which were proposed to be
involved in mechanotransduction, including TRPC1 and TRPV4,
interact with TRPP2 (Kottgen et al., 2008; Tsiokas et al., 1999).
However, none of those subunits had any effect on SAC activity
in the present study.
Alternatively, TRPP2 may affect SAC activity by interacting
with regulatory proteins, including elements of the cytoskeleton
such as a-actinin, CD2AP, mDia1, tropomyosin-1, and troponin
I (for reviews see Chen et al., 2008; Delmas, 2004; Harris and
Torres, 2009; Wilson, 2004). Here, we show that the actin cyto-
skeleton is indeed implicated in SAC inhibition by TRPP2, as
this effect was abolished by F-actin disruption. Moreover, the
actin stabilizer jasplakinolide mimicked the effect of TRPP2
and inhibited SAC activity, as expected from a stiffening of the
cytoskeleton (mechanoprotection). Additionally, we show that
FLNa is a novel cytoskeletal element interacting with TRPP2.
FLNa stiffens the cell cortex by virtue of its ability to crosslink
adjacent actin filaments and increases actin polymerization/
gelation rates in vitro (for review see Stossel et al., 2001). Conse-
Figure 6. TRPP2 Inhibition of SAC Activity
Requires FLNa
(A) Coimmunoprecipitation experiment demon-
strating the interaction between HA-tagged
TRPP2 and myc-tagged FLNa in cotransfected
COS cells. left lane, transfected with myc-tagged
FLNa; right lane, transfected with myc-tagged
FLNa and HA-tagged TRPP2. See Figure S12 for
whole blots.
(B) Mean SAC currents in M2 (FLNa KO) (n = 63)
and A7 (n = 66) cells (FLNa WT) at a holding poten-
tial of 80 mV.
(C) Mean (±SEM) NPo as a function of pressure in
FLNa KO (white) and FLNa WT (black) cells.
Expression of TRPP2 in FLNa KO (n = 48) and
FLNa WT (n = 57) cells did not affect single SAC
conductance (data not shown). Data are fitted
with Boltzmann functions (P0.5 = 25.0 ±
4.5 mmHg; 19.2 ± 5.6 mmHg; k = 16.6 ± 4.5;
16.4 ± 6.1, for FLNa KO and FLNA WT cells,
respectively).
(D) Mean (±SEM) SAC activity (NPo at70 mmHg)
of FLNa KO (white) and FLNa WT (black) cells
transfected with mock (GFP) or TRPP2. ** repre-
sents significant differences between TRPP2-
and mock-transfected condition (p < 0.01); NS,
not significant.
quently, localized increases in FLNa may
cause an accumulation of crosslinked
F-actin in the cell cortex and reduce
SAC activity (D’Addario et al., 2001; Kai-
nulainen et al., 2002). Here, we demonstrate that the activity of
nonselective SACs is reduced in the presence of FLNa and
that the inhibitory effect of TRPP2 is abolished when FLNa is
absent. However, we cannot exclude the possibility that
TRPP2 could directly interact with the SAC subunits, acting as
negative regulator, but in a FLNa/F-actin-dependent manner.
According to this scheme, TRPP2 could also be considered as
a SACs-FLNa linker.
Because the inhibitory effect of TRPP2 was present in the
mutant TRPP2-742X, which lacks an ER retention signal and is
thus more efficiently targeted to the plasma membrane, as well
as in the WT TRPP2, which is mainly found in the ER (Chen
et al., 2001; Mochizuki et al., 1996), the subcellular localization
of TRPP2 (ER versus plasma membrane) does not appear to
be essential for SAC inhibition (Figure S6).
Previous work on cloned SACs, including the bacterial channel
MscL or the mammalian channel TREK-1, indicate that these
channels are directly activated by membrane tension (the bilayer
model) (Honore´ et al., 2006; Kung, 2005; Sukharev et al., 1994).
The cortical cytoskeleton divides the bilayer into submicrometer
microdomains (Hamill and McBride, 1997; Sachs and Morris,
1998) whose radius of curvature is much smaller than the radii
of the patch or the cell (Figure 7). According to Laplace’s law,
T = Pr/2 (where T is tension, P pressure, and r radius of patch
curvature), tension in the bilayer decreases with the radius of
curvature (Hamill and McBride, 1997; Sachs and Morris, 1998).
Disruption of the cytoskeleton either chemically (latrunculin A)Cell 139, 587–596, October 30, 2009 ª2009 Elsevier Inc. 593
or mechanically results in an increase in the radius of curvature of
microdomains, leading to an increase in tension and SAC activity
for a given transmembrane pressure (Hamill and McBride, 1997;
Sachs and Morris, 1998; Wan et al., 1999). This mechanism
explains the increase in channel mechanosensitivity after cyto-
skeleton disruption (Hamill and McBride, 1997; Wan et al.,
1999). The data show that TRPP2 has the opposite effect, inhib-
iting SAC function via FLNa that reinforces F-actin (Figure 7).
This study is the first direct demonstration for the role of poly-
cystins in pressure sensing. The TRPP1/TRPP2 ratio controls
SAC mechanosensitivity through FLNa coupled to the actin cyto-
skeleton and affects the conversion of intraluminal pressure to
local bilayer tension. Our findings reveal a novel molecular mech-
anism explaining how polycystins regulate cellular mechanosen-
sitivity. This study is not only relevant to ADPKD but may also be
of importance for a better understanding of other physiological
or disease states associated with pressure sensing.
EXPERIMENTAL PROCEDURES
Dissociation of Vascular Smooth Muscle Cells
Male 12–16 weeks old mice of all three genotypes (Pkd1+/+, Pkd1SMdel/+, and
Pkd1SMdel/del) were used. Mice were anesthetized using isoflurane and their
gut was excised. A third-order mesenteric artery (<200 mm internal diameter,
3 to 5 mm length) was dissected and incubated (20 min at 37C) in a solution
Figure 7. Cartoon Illustrating the Bilayer Convoluted
by the Anchoring Cytoskeleton—‘‘The Upholstery
Model’’
With a given pressure (P) drop across the patch, the tension (T)
in the microdomain bilayer (100 nm scale) is a function of
their radius (r) of curvature rather than that of the mean curva-
ture of the patch. TRPP2 is represented at the plasma mem-
brane and in the membrane of the ER. The cytoskeleton lattice
mechanically reinforces the bilayer-protecting channels from
excess force. TRPP2 binding to FLNa increases actin cross-
linking and makes the microdomains smaller, so that
according to of Laplace’s Law (T = Pr/2) there will be less
tension for a given pressure. When TRPP2 or FLNa is absent,
when TRPP1 is coexpressed with TRPP2, or when the actin
cytoskeleton is disrupted with latrunculin A or cytochalasin
D, the microdomain radius of curvature increases, resulting
in a stronger activation of SACs for a given pressure.
of papain (1 mg/ml) and DTT (1 mg/ml), followed by a second
incubation (5 min at 37C) in a solution of collagenase F
(0.7 mg/ml) and collagenase H (0.3 mg/ml). The papain/DTT
and collagenase mixture was dissolved in DCML solution,
composed of 140 mM NaCl , 5.6 mM KCl, 2 mM MgCl2,
10 mM HEPES, 10 mM glucose, 0.1 mM CaCl2, and 1 mg/ml
bovine serum albumin. Arteries were rinsed three times in
DCML solution and triturated. Cell suspensions were placed
on 35 mm poly-D-lysine-coated dishes and kept at 4C for
at least 45 min before recording. Recordings were only per-
formed on elongated cells.
Electrophysiology
Electrophysiological procedure has been previously
described elsewhere (Chemin et al., 2005). Single channel
cell-attached recordings were performed on acutely dissoci-
ated VSMCs at a holding potential (Vhold) of 80 mV. Unless
stated otherwise, pipette solution contained 140 mM NaCl,
5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 10 mM TEA-Cl, 5 mM 4-AP, and
10 mM HEPES (pH 7.35). Bath solution contained 140 mM KCl, 1 mM
MgCl2, 10 mM HEPES, and 10 mM glucose (pH 7.25). The osmolality of all
solutions was adjusted to about 320 mOsm. Membrane patches were stimu-
lated with brief negative pressure pulses, from 0 to 100 mm Hg in steps of
10 mm Hg, through the recording electrode using a pressure-clamp device
(ALA High Speed Pressure Clamp-1 system; ALA-scientific). In whole-cell
recordings, for recording L-type Ca2+ channel currents, pipette solution con-
tained 110 mM CsCl, 20 mM TEA-Cl, 3 mM Na2ATP, 3.5 mM MgCl2, 10 mM
EGTA, 10 mM HEPES (pH 7.25) (300 mOsm). Bath solution contained
135 mM NaCl, 5 mM KCl, 10 mM BaCl2, 1 mM MgCl2, 10 mM HEPES,
10 mM glucose, 0.1 mM tetrodotoxin (pH 7.35). Cell capacitance was noted
for each recording, and no difference was observed between Pkd1+/+
(28.0 ± 1.7 pF; n = 22) and Pkd1SMdel/del (25.5 ± 1.6 pF; n = 15; p = 0.23) cells.
VSMCs were stimulated from a holding voltage of 60 mV with brief (0.4 s)
voltage steps from 90 to +60 mV in 10 mV increments. After a protocol
with normal external solution, a second one was performed in the presence
of 2 mM nifedipine. Subtracted current traces (control – nifedipine) are shown
in Figure 2.
For experiments with cultured cells, the pipette medium contained 150 mM
NaCl, 5 mM KCl, 1 mM CaCl2, and 10 mM HEPES (pH 7.4 with NaOH). The bath
medium contained 155 mM KCl, 5 mM EGTA, 3 mM MgCl2, and 10 mM HEPES
10 (pH 7.2 with KOH). The osmolality of all solutions was adjusted to about
320 mOsm. For ion-selectivity experiments, the external NaCl was replaced
by either sodium gluconate or choline chloride. In whole-cell recordings, F11
cells were superfused with normal bath NaCl solution, with bath solution at
pH 5.5 (for the ASIC channels), or with bath solution containing a cocktail of
K+ channel blockers (10 mM TEA, 5 mM 4-AP, and 10 mM glibenclamide). Vhold594 Cell 139, 587–596, October 30, 2009 ª2009 Elsevier Inc.
for all experiments was 80 mV. For K+ channel activity the cells were stimu-
lated with a voltage ramp (100 to +100 mV; 1 s). Current density was deter-
mined by dividing the subtracted current [stimulated current (pH 5.5) – baseline
current (pH 7.4)] by the cell capacitance, for the ASIC currents. Current density
was determined by dividing the subtracted current [current at +80 mV (no
blockers) – current at +80 mV (in the presence of K+ channel blockers)] by
the cell capacitance, for the K+ currents.
Cytoskeleton-disrupting agents (Sigma-Aldrich) were used as described in
the figure legends. Actin and tubulin polymerization was visualized by immu-
nofluorescence microscopy.
Isobaric Arteriography
Male mice aged between 12 and 16 weeks of all genotypes were used. Mice
were anesthetized using isoflurane and their was gut excised. A third-order
mesenteric artery (<200 mm internal diameter, 3 to 5 mm long) was dissected,
cannulated at both ends, and mounted in a video-monitored perfusion system
as previously described (Halpern and Kelley, 1991). The arterial segment was
bathed in a physiological solution (PSS) composed of 119 mM NaCl 119,
4.7 mM KCl, 2.5 mM CaCl2, 1.17 mM MgSO4, 25 mM NaHCO3, 1.18 mM
KH2PO4, 0.027 mM EDTA, and 5.5 mM glucose, oxygenated with a mixture
of CO2 (5%) and O2 (20%) in N2. The artery was pressurized at 75 mm Hg
and its diameter and wall thickness were measured and recorded continuously
using a video monitoring system (Living System Instrumentation Inc.). Data
were collected using the Spike2 software (CED) and analyzed offline. Vessels
were first allowed to stabilize for at least 30 min and were then stimulated with
80 mM KCl to verify vessel viability. Next, endothelium integrity was assessed
by testing the vasodilator effect of acetylcholine (1 mM) after preconstriction
with phenylephrine (1 mM). Then, a pressure diameter curve (active curve)
was established by increasing intraluminal pressure from 10 to 125 mm Hg
in a stepwise fashion (10, 25, 50, 75, 100, and 125). Pressure was then brought
back to 75 mm Hg and the PSS solution was changed to one without CaCl2
and with EGTA (5 mM), sodium nitroprusside (50 mM), and papaverine
(50 mM). After a 15 min incubation in the Ca-free PSS, a pressure-diameter
curve (passive curve) was performed. The KCl and phenylephrine responses
were calculated using the following formula: (D  D75P)/D75P; where D is the
amplitude of contraction and D75P is the lumen diameter under passive condi-
tions at 75 mm Hg. Percentage of myogenic tone at each pressure was calcu-
lated using the following formula: [(Dpass  Dact)/Dpass] 3 100, where Dpass is
the diameter under passive conditions and Dact under active conditions.
Stress-strain curves, an index of arterial elasticity, were established using
the following formulas. Stress: [(0.00133 3 Px 3 DPx)/(WL + WR)]; where Px is
the pressure (mm Hg), DPx the passive diameter at pressure x, and WL and
WR are the thickness of the left and right walls, respectively (in mm). Strain:
[(DPx  DP10)/DP10], where DP10 is the diameter at 10 mm Hg.
Cell culture, transfection, generation, and breeding of smooth muscle-
specific Pkd1 knockout mice, arterial pressure measurements, molecular
biology, siRNA transfection, real-time quantitative PCR, protein analysis,
immunohistochemistry, proteomic screen, and immunoprecipitation methods
are described in Supplemental Experimental Procedures.
SUPPLEMENTAL DATA
Supplemental Data contain Supplemental Experimental Procedures, 12
figures, and one table and can be found with this article online at http://
www.cell.com/supplemental/S0092-8674(09)01125-8.
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